Oxytetracycline Dihydrate

Verify with FDA CVM →

243 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
243
Total Reports
52
Deaths Reported
2140.0%
Death Rate

Active Ingredients

Oxytetracycline Dihydrate

Administration Routes

UnknownSubcutaneousIntramuscularIntravenousOralParenteralCutaneousOphthalmicTopicalOther

Species Affected

Unknown 123
Cattle 85
Human 15
Horse 9
Dog 7
Goat 2
Pig 1
Cat 1

Most Affected Breeds

Unknown 142
Aberdeen Angus 26
Cattle (unknown) 25
Cattle (other) 11
Crossbred Bovine/Cattle 4
Hereford cattle 4
Holstein-Friesian also known as Holstein 3
Red Angus 3
Mixed (Cattle) 2
Thoroughbred 2

Most Reported Reactions

Vials, Damaged 54
Death 44
Defect Unknown/Not Specified 34
Contamination NOS 34
Lack of efficacy - NOS 15
Injection site swelling 15
Bottles, Damaged 15
Anaphylaxis 13
Containers, Leaking 9
Lack of efficacy (bacteria) - NOS 7
Foaming at the mouth 7
Product Defect, General 7

Outcome Breakdown

Died
48 (34.0%)
Outcome Unknown
41 (29.1%)
Recovered/Normal
40 (28.4%)
Ongoing
7 (5.0%)
Euthanized
4 (2.8%)
Recovered with Sequela
1 (0.7%)

Data Summary

Metric Value
Total adverse event reports 243
Reports involving death 52
Case-fatality rate (reported events) 2140.0%
Distinct species in reports 8
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Oxytetracycline Dihydrate Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 243 adverse event reports referencing Oxytetracycline Dihydrate, including 52 reports in which the animal died — a 2140.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Oxytetracycline Dihydrate. Reported administration routes include Unknown, Subcutaneous, Intramuscular, Intravenous. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Oxytetracycline Dihydrate reports are Unknown (123 reports), Cattle (85 reports), Human (15 reports), with Unknown accounting for the largest share. Within those species, Unknown (142), Aberdeen Angus (26), Cattle (unknown) (25) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Oxytetracycline Dihydrate are Vials, Damaged (54), Death (44), Defect Unknown/Not Specified (34), Contamination NOS (34). Of the 141 reports with a coded outcome, Died is the leading category at 34.0%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Oxytetracycline Dihydrate.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial